Marker Therapeutics Statistics
Total Valuation
MRKR has a market cap or net worth of $19.01 million. The enterprise value is $3.45 million.
Important Dates
The last earnings date was Thursday, May 15, 2025, after market close.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MRKR has 11.31 million shares outstanding. The number of shares has increased by 7.64% in one year.
| Current Share Class | 11.31M |
| Shares Outstanding | 11.31M |
| Shares Change (YoY) | +7.64% |
| Shares Change (QoQ) | +21.02% |
| Owned by Insiders (%) | 2.52% |
| Owned by Institutions (%) | 16.94% |
| Float | 8.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.54 |
| Forward PS | 9.75 |
| PB Ratio | 1.18 |
| P/TBV Ratio | 1.18 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.61 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.79
| Current Ratio | 6.79 |
| Quick Ratio | 6.46 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -97.30% and return on invested capital (ROIC) is -60.53%.
| Return on Equity (ROE) | -97.30% |
| Return on Assets (ROA) | -51.17% |
| Return on Invested Capital (ROIC) | -60.53% |
| Return on Capital Employed (ROCE) | -87.81% |
| Revenue Per Employee | $1.14M |
| Profits Per Employee | -$2.56M |
| Employee Count | 5 |
| Asset Turnover | 0.37 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MRKR has paid $49,953 in taxes.
| Income Tax | 49,953 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.68% in the last 52 weeks. The beta is 1.45, so MRKR's price volatility has been higher than the market average.
| Beta (5Y) | 1.45 |
| 52-Week Price Change | -53.68% |
| 50-Day Moving Average | 1.20 |
| 200-Day Moving Average | 2.41 |
| Relative Strength Index (RSI) | 70.66 |
| Average Volume (20 Days) | 182,307 |
Short Selling Information
The latest short interest is 127,043, so 1.12% of the outstanding shares have been sold short.
| Short Interest | 127,043 |
| Short Previous Month | 126,685 |
| Short % of Shares Out | 1.12% |
| Short % of Float | 1.53% |
| Short Ratio (days to cover) | 3.26 |
Income Statement
In the last 12 months, MRKR had revenue of $5.70 million and -$12.78 million in losses. Loss per share was -$1.34.
| Revenue | 5.70M |
| Gross Profit | -8.33M |
| Operating Income | -12.72M |
| Pretax Income | -5.66M |
| Net Income | -12.78M |
| EBITDA | n/a |
| EBIT | -12.72M |
| Loss Per Share | -$1.34 |
Full Income StatementBalance Sheet
The company has $13.69 million in cash and n/a in debt, giving a net cash position of $13.69 million or $1.21 per share.
| Cash & Cash Equivalents | 13.69M |
| Total Debt | n/a |
| Net Cash | 13.69M |
| Net Cash Per Share | $1.21 |
| Equity (Book Value) | 14.49M |
| Book Value Per Share | 1.29 |
| Working Capital | 14.49M |
Full Balance SheetCash Flow
| Operating Cash Flow | -12.57M |
| Capital Expenditures | n/a |
| Free Cash Flow | -12.57M |
| FCF Per Share | -$1.11 |
Full Cash Flow StatementMargins
Gross margin is -146.28%, with operating and profit margins of -223.40% and -224.45%.
| Gross Margin | -146.28% |
| Operating Margin | -223.40% |
| Pretax Margin | -223.57% |
| Profit Margin | -224.45% |
| EBITDA Margin | n/a |
| EBIT Margin | -223.40% |
| FCF Margin | n/a |
Dividends & Yields
MRKR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.64% |
| Shareholder Yield | -7.64% |
| Earnings Yield | -74.58% |
| FCF Yield | -73.35% |
Analyst Forecast
The average price target for MRKR is $13.17, which is 683.93% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.17 |
| Price Target Difference | 683.93% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 105.98% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 27, 2023. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | Jan 27, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
MRKR has an Altman Z-Score of -30.78 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -30.78 |
| Piotroski F-Score | 4 |